Point-of-Care Guides

Diagnosis of Migraine Headache



FREE PREVIEW Log in or buy this issue to read the full article. AAFP members and paid subscribers get free access to all articles. Subscribe now.


FREE PREVIEW Subscribe or buy this issue. AAFP members and paid subscribers get free access to all articles.

Am Fam Physician. 2006 Dec 15;74(12):2087-2088.

Clinical Question

What is the best way to diagnose migraine in patients presenting with headache?

Evidence Summary

Headache is a common reason for primary care office visits and is a complaint in more than 1 percent of patient visits.1 The prevalence of migraine headache in the general population is approximately 6 percent in men and 15 percent in women, peaking at 40 years of age and then declining.2 The pretest probability of migraine in patients presenting to a primary care physician with a chief complaint of headache probably is higher than 6 to 15 percent because migraine headaches often are more severe and are accompanied by more diverse nonpain symptoms than other headaches. On the other hand, the pretest probability most likely is lower than the 75 percent prevalence seen in diagnostic studies of patients with possible migraine.3,4 For the purpose of this article, a reasonable estimate of migraine prevalence in patients with headache is 33 percent.

A meta-analysis identified nausea, photophobia, phonophobia, and exacerbation of headache with physical activity as the best individual symptoms for ruling in or out migraine.5 The best predictor is nausea (positive likelihood ratio [LR+] = 19.2). Given a 33 percent overall likelihood of migraine among patients presenting with headache, the presence of nausea alone increases the likelihood of migraine to 90 percent.5 The meta-analysis also confirmed that chocolate (LR+ = 7.1) and cheese (LR+ = 4.9) are the triggers most strongly associated with migraine.5

Several researchers have attempted to develop and validate clinical decision rules to diagnose migraine. Two researchers have developed rules for use in the primary care setting.3,4 In the first study, 1,049 French National Railway employees were asked screening questions.3 The 166 employees who had at least one headache every three months were included in the study.3 The participants were interviewed by a neurologist specializing in headache disorders, who made the final diagnosis using International Headache Society (IHS) criteria.3 Logistic regression was used to identify the best independent predictors of migraine.3  The five-item clinical decision rule from this study is shown in Table 1.2,3

TABLE 1

Five-Item Clinical Decision Rule for the Diagnosis of Migraine

No. of clinical featuresLikelihood ratioProbability of migraine in different populations (%)
Men in the general population (6% pretest*) Women in the general population (15% pretest*) Patients presenting in primary care with any headache (33% pretest*)

4 or 5

24

60

81

92

3

3.5

18

38

64

0 to 2

0.41

2.5

6.7

17

Clinical features

Pulsatile quality of headache

Headache duration of four to 72 hours

Unilateral headache

Nausea or vomiting

Disabling intensity of headache


*—Pretest probability is the likelihood of migraine before applying the decision rule.

Information from references 2 and 3.

TABLE 1   Five-Item Clinical Decision Rule for the Diagnosis of Migraine

View Table

TABLE 1

Five-Item Clinical Decision Rule for the Diagnosis of Migraine

No. of clinical featuresLikelihood ratioProbability of migraine in different populations (%)
Men in the general population (6% pretest*) Women in the general population (15% pretest*) Patients presenting in primary care with any headache (33% pretest*)

4 or 5

24

60

81

92

3

3.5

18

38

64

0 to 2

0.41

2.5

6.7

17

Clinical features

Pulsatile quality of headache

Headache duration of four to 72 hours

Unilateral headache

Nausea or vomiting

Disabling intensity of headache


*—Pretest probability is the likelihood of migraine before applying the decision rule.

Information from references 2 and 3.

In a more recent U.S. study, researchers developed the three-item Identification of Migraine (ID Migraine) clinical decision rule (Table 22,4) for the diagnosis of migraine.2 The same researchers validated the rule in a separate group of patients.4 The validation study included adults 18 to 55 years of age presenting at 27 primary care and 12 headache clinics.4 The mean age of patients was 39 years, and 75 percent were women. As in the first study, the reference standard was application of IHS criteria by a neurologist.4

TABLE 2

Identification of Migraine Clinical Decision Rule for the Diagnosis of Migraine

No. of clinical featuresLikelihood ratioProbability of migraine in different populations (%)
Men in the general population (6% pretest*) Women in the general population (15% pretest*) Patients presenting in primary care with any headache (33% pretest*)

2 or 3

3.2

17

36

62

0 or 1

0.25

1.6

4.2

11

Clinical features

Sensitivity to light

Nausea or vomiting

Disabling intensity of headache


*—Pretest probability is the likelihood of migraine before applying the decision rule.

Information from references 2 and 4.

TABLE 2   Identification of Migraine Clinical Decision Rule for the Diagnosis of Migraine

View Table

TABLE 2

Identification of Migraine Clinical Decision Rule for the Diagnosis of Migraine

No. of clinical featuresLikelihood ratioProbability of migraine in different populations (%)
Men in the general population (6% pretest*) Women in the general population (15% pretest*) Patients presenting in primary care with any headache (33% pretest*)

2 or 3

3.2

17

36

62

0 or 1

0.25

1.6

4.2

11

Clinical features

Sensitivity to light

Nausea or vomiting

Disabling intensity of headache


*—Pretest probability is the likelihood of migraine before applying the decision rule.

Information from references 2 and 4.

Although the methodology for both rules is strong, the ID Migraine rule has the advantage of being prospectively validated and can be used confidently as a self-administered tool. An additional advantage for American physicians is that it was validated in a domestic population.

It is important to remember that some of the features that make migraine more likely (e.g., photophobia, aura) also make it more likely that the patient will have a significant abnormality on an imaging study. Imaging is recommended for patients with high-risk features such as acute “thunderclap” headache (these patients also require lumbar puncture); abnormal neurologic examination findings; aura; vomiting, if not part of the patient’s usual migraine pattern; headache aggravated by exertion or Valsalva maneuver; or a nonclassic pattern of migraine, cluster, or tension headache.6 Imaging also should be considered in patients with new-onset headache, change in character of headache, or adult-onset migraine.6

Applying the Evidence

A 35-year-old woman has a recent history of headache episodes. Typically, her headaches are accompanied by nausea without vomiting or photophobia and are unilateral. The headaches last six to 12 hours, are usually gone when she awakens, and are fairly disabling. She denies having fever, weight loss, or other red flags for serious disease and has a normal neurologic examination. What is the probability that the patient has migraine headaches?

Answer: Based on the five-item clinical decision rule (Table 12,3), the patient has four out of five clinical features of migraine and, therefore, has a 92 percent probability of migraine. She also has a 62 percent probability (the highest possible) using the ID Migraine rule (Table 22,4). Because she has no red flags and a normal neurologic examination, you determine that imaging is not necessary, and you discuss migraine treatment options with the patient.

Address correspondence to Mark H. Ebell, M.D., M.S., at ebell@msu.edu. Reprints are not available from the author.

REFERENCES

1. Cherry DK, Woodwell DA. National ambulatory medical care survey: 2000 summary. Adv Data. 2002;328:1–32.

2. Stewart WF, Shechter A, Rasmussen BK. Migraine prevalence. A review of population-based studies. Neurology. 1994;44(6 suppl 4):S17–23.

3. Michel P, Henry P, Letenneur L, Jogeix M, Corson A, Datigues JF. Diagnostic screen for assessment of the IHS criteria for migraine by general practitioners. Cephalalgia. 1993;13(suppl 12):54–9.

4. Lipton RB, Dodick D, Sadovsky R, Kolodner K, Endicott J, Hettiarachchi J, et al. A self-administered screener for migraine in primary care: the ID Migraine validation study. Neurology. 2003;61:375–82.

5. Smetana GW. The diagnostic value of historical features in primary headache syndromes: a comprehensive review. Arch Intern Med. 2000;160:2729–37.

6. Detsky ME, McDonald DR, Baerlocher MO, Tomlinson GA, McCrory DC, Booth CM. Does this patient with headache have a migraine or need neuroimaging?. JAMA. 2006;296:1274–83.

This guide is one in a series that offers evidence-based tools to assist family physicians in improving their decision making at the point of care.



Copyright © 2006 by the American Academy of Family Physicians.
This content is owned by the AAFP. A person viewing it online may make one printout of the material and may use that printout only for his or her personal, non-commercial reference. This material may not otherwise be downloaded, copied, printed, stored, transmitted or reproduced in any medium, whether now known or later invented, except as authorized in writing by the AAFP. Contact afpserv@aafp.org for copyright questions and/or permission requests.

Want to use this article elsewhere? Get Permissions


Article Tools

  • Print page
  • Share this page
  • AFP CME Quiz

Information From Industry

More in AFP

More in Pubmed

Navigate this Article